Use of multilayer controlled release tablets comprising ropinirole in the manufacture of a medicament for the treatment of fibromyalgia

摘要

The invention relates to the use of a dosage formulation or tablet comprising a mixed matrix of hydrophilic and lipophilic components able to control the release rate of ropinirole or a pharmaceutically acceptable salt thereof from the formulation/tablet in the continual treatment of fibromyalgia.